Anti-ATOX1 monoclonal antibody
Pre-made anti-ATOX1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to ATOX1/ATOX1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP2366-Ab-1/ GM-Tg-hg-IP2366-Ab-2 | Anti-Human ATOX1 monoclonal antibody | Human |
GM-Tg-rg-IP2366-Ab-1/ GM-Tg-rg-IP2366-Ab-2 | Anti-Rat ATOX1 monoclonal antibody | Rat |
GM-Tg-mg-IP2366-Ab-1/ GM-Tg-mg-IP2366-Ab-2 | Anti-Mouse ATOX1 monoclonal antibody | Mouse |
GM-Tg-cynog-IP2366-Ab-1/ GM-Tg-cynog-IP2366-Ab-2 | Anti-Cynomolgus/ Rhesus macaque ATOX1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP2366-Ab-1/ GM-Tg-felg-IP2366-Ab-2 | Anti-Feline ATOX1 monoclonal antibody | Feline |
GM-Tg-cang-IP2366-Ab-1/ GM-Tg-cang-IP2366-Ab-2 | Anti-Canine ATOX1 monoclonal antibody | Canine |
GM-Tg-bovg-IP2366-Ab-1/ GM-Tg-bovg-IP2366-Ab-2 | Anti-Bovine ATOX1 monoclonal antibody | Bovine |
GM-Tg-equg-IP2366-Ab-1/ GM-Tg-equg-IP2366-Ab-2 | Anti-Equine ATOX1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP2366-Ab-1/ GM-Tg-hg-IP2366-Ab-2; GM-Tg-rg-IP2366-Ab-1/ GM-Tg-rg-IP2366-Ab-2; GM-Tg-mg-IP2366-Ab-1/ GM-Tg-mg-IP2366-Ab-2; GM-Tg-cynog-IP2366-Ab-1/ GM-Tg-cynog-IP2366-Ab-2; GM-Tg-felg-IP2366-Ab-1/ GM-Tg-felg-IP2366-Ab-2; GM-Tg-cang-IP2366-Ab-1/ GM-Tg-cang-IP2366-Ab-2; GM-Tg-bovg-IP2366-Ab-1/ GM-Tg-bovg-IP2366-Ab-2; GM-Tg-equg-IP2366-Ab-1/ GM-Tg-equg-IP2366-Ab-2 |
Products Name | Anti-ATOX1 monoclonal antibody |
Format | mab |
Target Name | ATOX1 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-ATOX1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP2366-Ag-1 | Recombinant multi-species ATOX1/ ATX1/ HAH1 protein |
ORF Viral Vector | pGMLP000187 | human ATOX1 Lentivirus plasmid |
ORF Viral Vector | vGMLP000187 | human ATOX1 Lentivirus particle |
ORF Viral Vector | pGMLPm003705 | mouse Atox1 Lentivirus plasmid |
ORF Viral Vector | vGMLPm003705 | mouse Atox1 Lentivirus particle |
Target information
Target ID | GM-IP2366 |
Target Name | ATOX1 |
Gene ID | 475,11927,84355,712464,403713,101084170,613998,100071499 |
Gene Symbol and Synonyms | ATOX1,ATX1,HAH1 |
Uniprot Accession | O00244,Q9WUC4,Q9TT99,Q3T0E0 |
Uniprot Entry Name | ATOX1_HUMAN,ATOX1_RAT,ATOX1_CANLF,ATOX1_BOVIN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000177556 |
Target Classification | N/A |
The target: ATOX1, gene name: ATOX1, also named as ATX1, HAH1. This gene encodes a copper chaperone that plays a role in copper homeostasis by binding and transporting cytosolic copper to ATPase proteins in the trans-Golgi network for later incorporation to the ceruloplasmin. This protein also functions as an antioxidant against superoxide and hydrogen peroxide, and therefore, may play a significant role in cancer carcinogenesis. Because of its cytogenetic location, this gene represents a candidate gene for 5q-syndrome. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.